Connection

Sheldon Litwin to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Sheldon Litwin has written about Hypoglycemic Agents.
Sheldon Litwin
Connection Strength
0.481
Hypoglycemic Agents
  1. Hyperglycemia and adverse outcomes in acute coronary syndromes: is serum glucose the provocateur or innocent bystander? Diabetes. 2014 Jul; 63(7):2209-12.
    View in: PubMed
    Score: 0.384
  2. JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk. J Clin Lipidol. 2022 Mar-Apr; 16(2):115-127.
    View in: PubMed
    Score: 0.041
  3. Lessons from SGLT-2 inhibitors: rethinking endpoints for heart failure studies. Nat Med. 2021 11; 27(11):1872-1873.
    View in: PubMed
    Score: 0.040
  4. Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab. 2008 Dec; 8(6):482-91.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.